Skip to end of metadata
Go to start of metadata

Most Drug and Substance changes have been presented in the recent Alpha release, however the numbers are still evolving and will likely change before the final version of the release notes are generated in July. Some of the changes include Use of additional Axioms, which is explained in details in this briefing 

Briefing note - Use of Additional Axiom Functionality and Remodeling Product Roles.pdf 

Briefing note - Implications of describing liquid dose form product concepts using presentation strength.pdf

  • No labels